MedTrace Logo

Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy

NCT04172311 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-11-21

No results posted yet for this study

Summary

In this study, the efficacy of add-on modified Atkins diet will be compared with add-on Levetiracetam in children with refractory epilepsy in a randomized open label trial. The results will aid clinicians in deciding the treatment options when a child has been diagnosed to have refractory epilepsy.

Conditions

  • Refractory Childhood Epilepsy

Interventions

OTHER

Modified Atkins Diet

Modified Atkins diet is a type of ketogenic diet which is less restrictive

DRUG

Levetiracetam

Levetiracetam is a second generation anti-epileptic drug which is broad spectrum and commonly used as add-on in refractory epilepsy

Sponsors & Collaborators

  • Lady Hardinge Medical College

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2021-03-31
Completion
2021-04-20

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04172311 on ClinicalTrials.gov